Literature DB >> 3048052

The Stockholm Diabetes Intervention Study (SDIS): 18 months' results.

P Reichard1, A Britz, I Cars, B Y Nilsson, B Sobocinsky-Olsson, U Rosenqvist.   

Abstract

Patients with insulin-dependent diabetes mellitus (IDDM), non-proliferative retinopathy and unsatisfactory blood glucose control were randomized to intensified conventional treatment (ICT, 48 patients) or regular treatment (RT, 54 patients) for a 5-year study. After 18 months the glycosylated hemoglobin (HbA1c) was reduced in both groups, but significantly more in the ICT group (p = 0.00005). Thirty of the RT patients and 16 from the ICT group deteriorated as to retinopathy (p = 0.024). Microalbuminuria appeared more often in the RT patients (p = 0.023), and nerve conduction velocities were significantly reduced only in the RT group (p between 0.0005 and 0.047). Serious hypoglycemia was more common in the ICT patients (p = 0.003). The progression of diabetic late complications was thus slowed down by intensified treatment, but at the price of an increased frequency of serious hypoglycemia.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3048052     DOI: 10.1111/j.0954-6820.1988.tb16748.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  11 in total

1.  Bioavailability of immediate- and extended-release formulations of glipizide in healthy male volunteers.

Authors:  Sanju Dhawan; Bhupinder Singh; Santosh Kumar Garg; Debasish Hota; Radharaman Jiban Dash; Anil Kumar Singla; Vivek Ranjan Sinha
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

Review 2.  Glucose targets for preventing diabetic kidney disease and its progression.

Authors:  Marinella Ruospo; Valeria M Saglimbene; Suetonia C Palmer; Salvatore De Cosmo; Antonio Pacilli; Olga Lamacchia; Mauro Cignarelli; Paola Fioretto; Mariacristina Vecchio; Jonathan C Craig; Giovanni Fm Strippoli
Journal:  Cochrane Database Syst Rev       Date:  2017-06-08

3.  Intensified insulin treatment is associated with improvement in skin microcirculation and ischaemic foot ulcer in patients with type 1 diabetes mellitus: a long-term follow-up study.

Authors:  Björn Rathsman; Kerstin Jensen-Urstad; Thomas Nyström
Journal:  Diabetologia       Date:  2014-05-07       Impact factor: 10.122

Review 4.  Diabetes: glycaemic control in type 1.

Authors:  Bala Srinivasan; Melanie Davies; Ian Lawrence
Journal:  BMJ Clin Evid       Date:  2008-07-30

5.  Background factors, long-term complications, quality of life and metabolic control in insulin dependent diabetes.

Authors:  A Wikby; J O Hörnquist; U Stenström; P O Andersson
Journal:  Qual Life Res       Date:  1993-08       Impact factor: 4.147

Review 6.  A risk-benefit assessment of conventional versus intensive insulin therapy.

Authors:  P Reichard
Journal:  Drug Saf       Date:  1994-03       Impact factor: 5.606

7.  Intensified conventional insulin treatment and neuropsychological impairment.

Authors:  P Reichard; A Britz; U Rosenqvist
Journal:  BMJ       Date:  1991-12-07

8.  Blood glucose concentrations and progression of diabetic retinopathy: the seven year results of the Oslo study.

Authors:  O Brinchmann-Hansen; K Dahl-Jørgensen; L Sandvik; K F Hanssen
Journal:  BMJ       Date:  1992-01-04

Review 9.  Insulin and Its Cardiovascular Effects: What Is the Current Evidence?

Authors:  Sahana Pai Dongerkery; Pamela R Schroeder; Mansur E Shomali
Journal:  Curr Diab Rep       Date:  2017-10-23       Impact factor: 4.810

Review 10.  Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease.

Authors:  Clement Lo; Tadashi Toyama; Ying Wang; Jin Lin; Yoichiro Hirakawa; Min Jun; Alan Cass; Carmel M Hawley; Helen Pilmore; Sunil V Badve; Vlado Perkovic; Sophia Zoungas
Journal:  Cochrane Database Syst Rev       Date:  2018-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.